We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Bracco Diagnostics Acquires E-Z-EM

By HospiMedica staff writers
Posted on 31 Oct 2007
Bracco Diagnostics, a US based subsidiary of Bracco Imaging, S.p.A and part of the Bracco group, announced the acquisition of E-Z-EM, a recognized contrast agent manufacturer for diagnostic imaging of the GI tract. More...


E-Z-EM and Bracco Diagnostics have a longstanding association: E-Z-EM manufactures an oral imaging product for Bracco, and Bracco, as distributors, represents E-Z-EM in Italy. Bracco Diagnostics is one of the world's leading companies in the imaging agent business, while E-Z-EM is a leading manufacturer of contrast agents for gastrointestinal radiology. In addition, it is worth noting that E-Z-EM was named among the Best Small Companies in America in 2007 by Forbes magazine.

Both companies are well positioned with respected brands in the marketplace and the expected synergies from the merger will certainly enhance their standing. Bracco believes in the strong strategic fit of E-Z-EM to strengthen its core business and to consolidate its presence in the sector. In fact, the merger represent an initiative pursued by the E-Z-EM board of directors as the best alternative to increase shareholder value.

Under the terms of the agreement, Bracco will acquire all outstanding shares of E-Z-EM for US$21 per share for a total consideration of nearly $241 million. Subject to a majority vote by E-Z-EM shareholders and U.S. regulatory approval, the transaction will close sometime early in 2008, with a merger by incorporation of E-Z-EM into Bracco Diagnostics.

E-Z-EM (Lake Success, NY, USA) is a leading manufacturer of contrast agents for radiology and the developer of VoLumen, a next generation low-density barium sulfate suspension for use as an oral contrast in Multidetector CT (MDCT) and Positron Emission Tomography (PET/CT) studies. E-Z-EM is also the worldwide manufacturer and marketer of Reactive Skin Decontamination Lotion (RSDL), a broad-spectrum liquid chemical warfare agent decontaminant.

Bracco Diagnostics, Inc., (Princeton, NJ, USA) one of the world's leading companies in the imaging agent business, is a US subsidiary of Bracco Imaging S.p.A of Milan, Italy, which also markets ethical, and OTC pharmaceutical products and healthcare services in Italy, as well as advanced medical technology systems on a worldwide basis.


Related Links:
E-Z-EM
Bracco Diagnostics

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Tourniquet System
heidi– mein Tourniquet
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Emergency Department Campaign Reduces CT Use Without Identified Missed Injuries

Unnecessary head and cervical spine computed tomography (CT) in low-risk trauma patients exposes them to avoidable radiation, prolongs emergency department stays, and increases healthcare costs.... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.